[1]
Mofid, B., Razzaghdoust, A., Ghajari, M. , Basiri, A. , Fattahi, M.-R. , Houshyari, M. , Jafari, A. and Taghizadeh-Hesary, F. 2022. Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis: Neoadjuvant carboplatin in locally advanced bladder cancer. Urology Journal. 19, 05 (Nov. 2022), 371–378. DOI:https://doi.org/10.22037/uj.v19i05.6841.